Drug Chatter -- Tracking biopharma stock chatter

Profile for Spark Therapeutics, Inc. (ONCE)

« Back to company index

ONCE Chatter Timeline

Stock Ticker for ONCE

Most Active Tweeters for ONCE

UserTweets
@ConsumerFeed 16
@AmericanBanking 12
@intercooleronli 11
@TickerReport 10
@TheMarketsDaily 9

Recent Tweets for ONCE

BradBailey3331 @BradBailey3331
has anyone used this? i've been getting in on some great trades because of it https://t.co/LqzdHVuBKV $SPLK $ONCE… https://t.co/n5PNjhPWfZ
12:11am
ConsumerFeed @ConsumerFeed
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Spark Therapeutics $ONCE Stock Price https://t.co/f0iw1EGKXq
November 16th 2017, 9:11pm
dakotafinancial @dakotafinancial
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Spark Therapeutics $ONCE Stock Price https://t.co/YJviXeas35
November 16th 2017, 9:11pm
smrtreddyk @smrtreddyk
RT @AlpBugraBasat: $ONCE is also a reasonable M&A target, there is a lot more to do in retina/CNS with their vector, imho.
November 16th 2017, 8:11pm
AlpBugraBasat @AlpBugraBasat
$ONCE is also a reasonable M&A target, there is a lot more to do in retina/CNS with their vector, imho.
November 16th 2017, 8:11pm
midetimes @midetimes
Spark Therapeutics, Inc. $ONCE Receives “Buy” Rating from BMO Capital Markets https://t.co/6R1nCU2IBE
November 16th 2017, 7:11pm
WKRBNews @WKRBNews
Spark Therapeutics, Inc. $ONCE Receives “Buy” Rating from BMO Capital Markets https://t.co/64CwaVFjVT
November 16th 2017, 7:11pm
dailymailtimes @dailymailtimes
Spark Therapeutics, Inc. $ONCE Receives “Buy” Rating from BMO Capital Markets https://t.co/33W2bsC8e7
November 16th 2017, 7:11pm
dailypoliticaln @dailypoliticaln
Spark Therapeutics, Inc. $ONCE Receives “Buy” Rating from BMO Capital Markets https://t.co/xIDvvW9QCs
November 16th 2017, 7:11pm
bradloncar @bradloncar
Did ICER recommend an alternative price they believe $ONCE’s gene therapy would be cost effective? Or did they just… https://t.co/6yrlEvXdeT
November 16th 2017, 6:11pm
wulamkam @wulamkam
$once could see a weekly hammer to the 50 week moving avg by tomorrow? https://t.co/04zCYoekJS
November 16th 2017, 4:11pm
stocktrader300 @stocktrader300
$ONCE still going
November 16th 2017, 3:11pm
canuck2usa @canuck2usa
$ONCE decent start ?? https://t.co/MdCxydomAG
November 16th 2017, 3:11pm
CFinancialNews @CFinancialNews
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/tDcTmbYbML
November 16th 2017, 2:11pm
AmericanBanking @AmericanBanking
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/0I48zLK23m
November 16th 2017, 2:11pm
WatchlistN @WatchlistN
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/XKEFjzB8Qa
November 16th 2017, 2:11pm
intercooleronli @intercooleronli
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/hAzbAF57og
November 16th 2017, 2:11pm
ConsumerFeed @ConsumerFeed
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/b1aKSGHTTC #acn
November 16th 2017, 2:11pm
stocknewstimes @stocknewstimes
Spark Therapeutics, Inc. $ONCE Receives Consensus Recommendation of “Buy” from Analysts https://t.co/oC9PR8DxpC
November 16th 2017, 2:11pm
JohnCendpts @JohnCendpts
I'm just going to keep adding to my #ASH17 preview until my whole schedule is filled up. Adding $ONCE -- email any… https://t.co/JzjhOt0ZDM
November 16th 2017, 1:11pm
kjilly @kjilly
You want to charge $1M for that #genetherapy? Here’s where you’re wrong #biotech #pharma #drugprices #ICER $ONCE https://t.co/5oDhRvugDT
November 16th 2017, 1:11pm
dispatchtribune @dispatchtribune
ValuEngine Downgrades Spark Therapeutics, Inc. $ONCE to Sell https://t.co/ARBnEcWuJa
November 16th 2017, 1:11pm
KnoxOfWallSt99 @KnoxOfWallSt99
I highly recommend everyone check this out for discovering great stocks to trade https://t.co/2A8kJceqmY $ONCE… https://t.co/MNAsT4YBXW
November 16th 2017, 1:11pm
SwatOptions @SwatOptions
@canuck2usa Funny... "Once upon a time" from yesterday ;) take it home my friend $ONCE https://t.co/wALubby18c
November 16th 2017, 10:11am
canuck2usa @canuck2usa
$ONCE nice so far
November 16th 2017, 10:11am
chaffeybreeze @chaffeybreeze
Jennison Associates LLC Invests $27.24 Million in Spark Therapeutics, Inc. $ONCE https://t.co/m1dZCIWbIp
November 16th 2017, 10:11am
IRAMarketReport @IRAMarketReport
Jennison Associates LLC Invests $27.24 Million in Spark Therapeutics, Inc. $ONCE https://t.co/0CicwjdRYP
November 16th 2017, 10:11am
m_denniswinters @m_denniswinters
$once let them eat cake ;) https://t.co/i9QWifHj9k
November 16th 2017, 9:11am
dailymailtimes @dailymailtimes
Spark Therapeutics, Inc. $ONCE Insider Sells $392,920.00 in Stock https://t.co/yoD9frdCWq
November 16th 2017, 9:11am
WKRBNews @WKRBNews
Spark Therapeutics, Inc. $ONCE Insider Sells $392,920.00 in Stock https://t.co/LAdWoEkI1c
November 16th 2017, 9:11am
dailypoliticaln @dailypoliticaln
Spark Therapeutics, Inc. $ONCE Insider Sells $392,920.00 in Stock https://t.co/2gxGXF4btj
November 16th 2017, 9:11am
midetimes @midetimes
Spark Therapeutics, Inc. $ONCE Insider Sells $392,920.00 in Stock https://t.co/nR1D7HCDY4
November 16th 2017, 9:11am
WeekHerald @WeekHerald
Insider Selling: Spark Therapeutics, Inc. $ONCE CEO Sells $1,430,800.00 in Stock https://t.co/BXNXBLfqFl
November 16th 2017, 8:11am
JacobPlieth @JacobPlieth
Gene therapy pricing? Webster ( $ONCE ): If it works pay us. If not, stop paying us #Jefferies17
November 16th 2017, 7:11am
TheMarketsDaily @TheMarketsDaily
Spark Therapeutics, Inc. $ONCE Stock Price Down 0.6% Following Insider Selling https://t.co/eu1Uza3wmc
November 16th 2017, 2:11am
CFinancialNews @CFinancialNews
BMO Capital Markets Reiterates Buy Rating for Spark Therapeutics, Inc. $ONCE https://t.co/586roycSxT
November 15th 2017, 11:11pm
intercooleronli @intercooleronli
BMO Capital Markets Reiterates Buy Rating for Spark Therapeutics, Inc. $ONCE https://t.co/3MjXxEInyf
November 15th 2017, 11:11pm
ConsumerFeed @ConsumerFeed
BMO Capital Markets Reiterates Buy Rating for Spark Therapeutics, Inc. $ONCE https://t.co/OdEBri64xZ #acn
November 15th 2017, 11:11pm
RatingsNetwork @RatingsNetwork
Spark Therapeutics's buy rating reiterated at BMO Capital Markets. $101.00 PT. https://t.co/F2bC00vaux $ONCE #ONCE
November 15th 2017, 11:11pm
ConsumerFeed @ConsumerFeed
Spark Therapeutics's buy rating reiterated at BMO Capital Markets. $101.00 PT. https://t.co/GHl5rnz3K4 $ONCE #ONCE
November 15th 2017, 11:11pm
ARatings @ARatings
BMO Capital Keeps Their Buy Rating on Spark Therapeutics $ONCE https://t.co/Guy9qNgCIJ
November 15th 2017, 9:11pm
wcumsjy @wcumsjy
RT @EPVantage: Vantage Snippet – ICER makes cost-effectiveness calculation on gene therapy Luxturna $ONCE https://t.co/ixEUxeOvBf
November 15th 2017, 6:11pm
dailymailtimes @dailymailtimes
Spark Therapeutics, Inc. $ONCE Downgraded by ValuEngine to Sell https://t.co/bXeWDMGCBI
November 15th 2017, 4:11pm
midetimes @midetimes
Spark Therapeutics, Inc. $ONCE Downgraded by ValuEngine to Sell https://t.co/2pyc1OrwBu
November 15th 2017, 4:11pm
dailypoliticaln @dailypoliticaln
Spark Therapeutics, Inc. $ONCE Downgraded by ValuEngine to Sell https://t.co/VJAUogjyBt
November 15th 2017, 4:11pm
WKRBNews @WKRBNews
Spark Therapeutics, Inc. $ONCE Downgraded by ValuEngine to Sell https://t.co/2B4U13pS3G
November 15th 2017, 4:11pm
BatScientist @BatScientist
$ONCE 200 SMA support ? https://t.co/JfHcPvJD08
November 15th 2017, 1:11pm
datamonitor_JA @datamonitor_JA
RT @amandamicklus: Expect this to create difficult discussions w/ payers $ONCE https://t.co/OCbgw6tzrD
November 15th 2017, 1:11pm
amandamicklus @amandamicklus
Expect this to create difficult discussions w/ payers $ONCE https://t.co/OCbgw6tzrD
November 15th 2017, 12:11pm
EPVantage @EPVantage
Vantage Snippet – ICER makes cost-effectiveness calculation on gene therapy Luxturna $ONCE https://t.co/ixEUxeOvBf
November 15th 2017, 12:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.